Abstract
Charcot neuroarthropathy (CN) of the foot is uncommon and CN of atypical sites like wrist is sparingly described. CN is grossly under-diagnosed or misdiagnosed by primary care physicians. CN may present in acute phase with classical signs of inflammation or with deformities in chronic phase. The present study describes varied presentations, diagnostic dilemmas, and outcomes of CN in patients with diabetes. Data from the electronic repository of patients with diabetes and foot complications was obtained. The repository has a pre-designed structured format for information pertaining to the patients’ anthropometry, presentation, neurological, vascular and foot examination details, treatment offered, and outcomes on follow-up. In addition, literature search for prior reported cases of atypical site (wrist) of CN was conducted. Data of 206 subjects with foot CN and two cases of atypical joint amongst 1297 patients with diabetes mellitus was screened. The particulars of patients with varied presentation viz. acute phase (case 1), stable foot deformities in chronic phase (case 2), and unstable foot with destruction of ankle joint in hindfoot CN (case 3) are presented along with the differential diagnosis and their outcomes on follow-up at 36 months of presentation. A literature search for atypical site of CN revealed only nine cases of wrist CN. The diagnosis of wrist CN was not initially considered and misdiagnosed. Patient with CN may present in active phase or more commonly with deformities and destroyed joints. The acute CN is misdiagnosed as cellulitis and inadvertently treated with antibiotics. Wrist and MCP joint CN is extremely rare and the diagnosis of CN requires a high index of suspicion supported by radiography findings.
Similar content being viewed by others
References
Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000;23:796–800.
Jeffcoate WJ. Charcot foot syndrome. Diabet Med. 2015;32(6):760–70.
Cavangh PR, Young MJ, Adams JE, Vickers KL, Boulton AJ. Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care. 1994;17:201–9.
Bhansali A, Dutta P, Bhatt MH, Singh P, Aggrawal A, Mittal BR. The Charcot neuroarthropathy of the elbow in type 2 diabetes mellitus. Endocrinologist. 2009;19:171–3.
Feldman MJ, Becker KL, Reefe WE, Longo A. Multiple neuropathic joints, including the wrist in a patient with diabetes mellitus. JAMA. 1969;209:1690–2.
Bayne O, Lu EJ. Diabetic Charcot’s arthropathy of the wrist. Case report and literature review. Clin Orthop Relat Res. 1998;357:122–6.
Lambert PA, Close CF. Charcot neuroarthropathy of the wrist in type 1 diabetes. Diabetes Care. 2005;28:984–5.
Wŕobel M, Szymborska-Kajanek A, Skiba M, et al. Charcot’s joint of the wrist in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2007;115:55–7.
Gökhan C¸ Erkan K¸ Levent Ö. Acute Charcot arthropathy of wrist in a diabetic patient. Rheumatol Int 2013 33:2959–2960.
Illgner U, Netten JV, Droste C, Meiners T, Postema K, Wetz HH. Diabetic Charcot neuroarthropathy of the hand: clinical course, diagnosis and treatment options. Diabetes Care. 2014;37:e91–2.
Pakarinen TK, Laine HJ, Honkonen SE, Peltonen J, Oksala H, Lahtela J. Charcot arthropathy of the diabetic foot: current concepts and review of 36 cases. Scand J Surg. 2002;91:195–201.
Sinha S, Munichoodappa C, Kozak GP. Neuroarthropathy Charcot’s joint in diabetes mellitus: a clinical study of 101 cases. Medicine (Baltimore). 1972;51:192–210.
Eichenholtz SN. Charcot joints. Springfield: Charles C, Thomas; 1966. p. 7–8.
Perkins BA, Olaleye D, Bril V. Carpal tunnel syndrome in patients with diabetic polyneuropathy. Diabetes Care. 2002;25:565–9.
Dyck P, Kratz K, Karnes J, Litchy W, Klein R, Pach J, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43:817–24.
Harden RN, Oaklander AL, Burton AW, Perez RS, Richardson K, Swan M, et al. Complex regional pain syndrome: practical diagnostic and treatment guidelines. 4th edition. Pain Med. 2013;14:180–229.
Harden RN, Bruehl S, Perez RS, Birklein F, Marinus J, Maihofner C, et al. Validation of proposed diagnostic criteria (the “Budapest criteria”) for complex regional pain syndrome. Pain. 2010;150:268–74.
Charcot JM. Sur quelques arthropathies qui paraissent dépendre d’une lésion du cerveau ou de la moëlle épinière. Arch Physiol Norm Pathol. 1868;1:161–78.
Jordan WR. Neuritic manifestations in diabetes mellitus. Arch Intern Med. 1936;57:307–58.
Chisholm KA, Gilchrist JM. The Charcot joint: a modern neurologic perspective. J Clin Neuromuscul Dis. 2011;13:1–13.
Jeffcoate W, Lipsky BA. Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. Clin Infect Dis. 2004;39(Suppl 2):S115–22.
Game FL, Catlow R, Jones GR, Edmonds ME, Jude EB, Rayman G, et al. Audit of acute Charcot’s disease in the UK: the CDUK study. Diabetologia. 2012;55:32–5.
Wang L, Shi X, Zhao R, Halloran BP, Clark DJ. Calcitonin- gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-kappa B activation, osteoclastogenesis and bone resorption. Bone. 2010;46:1369–79.
Ndip A, Williams A, Jude EB, Serracino-Inglott F. The RANKL/RANK/OPG signaling pathway mediates medial arterial calcification in diabetic Charcot neuroarthropathy. Diabetes. 2011;60:2187–96.
Jude EB, Selby PL, Burgess J, Lilleystone P, Mawer EB, Page SR, et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia. 2001;44:2032–7.
Pakarinen T-K, Laine H-J, Maenpaa H, Mattila P, Lahtela J. The effect of zoledronic acid on the clinical resolution of Charcot neuroarthropathy. Diabetes Care. 2011;34:1514–6.
Richard JL, Almasari M, Schuldiner S. Treatment of acute Charcot foot with bisphosphonates: a systematic review of the literature. Diabetologia. 2012;55:1258–64.
Author information
Authors and Affiliations
Contributions
AR was involved in the clinical care of the patient, literature search, and writing and editing of the manuscript. MP provided inputs for radiological imaging. AB was involved in writing and editing of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict interests.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Rights and permissions
About this article
Cite this article
Rastogi, A., Prakash, M. & Bhansali, A. Varied presentations and outcomes of Charcot neuroarthropathy in patients with diabetes mellitus. Int J Diabetes Dev Ctries 39, 513–522 (2019). https://doi.org/10.1007/s13410-018-0700-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13410-018-0700-8